Search research articles
Contact Us
Filters
Showing results (791-800 of 1,030) with videos related to
Page
of 103
Sort By:
Journal of Addiction Medicine
|
July 20, 2011
Interrelated effects of substance use diagnosis, race, and smoking severity on abstinence initiation in dually dependent male smokers: results of a retrospective chart review
Jaimee L Heffner, Thomas J Blom, Elaine Camerota, et al.
Cancer
|
March 8, 2011
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond
Lisa Lima, Leon Bernal-Mizrachi, Debra Saxe, et al.
Blood
|
March 21, 2009
Generation of induced pluripotent stem cells from human blood
Yuin-Han Loh, Suneet Agarwal, In-Hyun Park, et al.
Neuropharmacology
|
January 1, 1997
The pharmacology of the novel and selective sigma ligand, PD 144418
H C Akunne, S Z Whetzel, J N Wiley, et al.
Journal of Studies on Alcohol and Drugs
|
March 21, 2017
Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men
Melodie Isgro, Neal Doran, Jaimee L Heffner, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia
Meir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Journal of Medicinal Chemistry
|
December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents
P C Unangst, T Capiris, D T Connor, et al.
Journal of Medicinal Chemistry
|
January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties
J C Jaen, L D Wise, B W Caprathe, et al.
Brain : a Journal of Neurology
|
October 13, 2006
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome
Mario Masellis, Parastoo Momeni, Wendy Meschino, et al.
Cancer
|
July 1, 2011
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years
Martha Arellano, Elliott Winton, Lin Pan, et al.
Page
of 103
Search research articles
Search
Showing results (791-800 of 1,030) with videos related to
Sort By:
Page
of 103
Journal of Addiction Medicine
|
July 20, 2011
Interrelated effects of substance use diagnosis, race, and smoking severity on abstinence initiation in dually dependent male smokers: results of a retrospective chart review
Jaimee L Heffner, Thomas J Blom, Elaine Camerota, et al.
Cancer
|
March 8, 2011
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond
Lisa Lima, Leon Bernal-Mizrachi, Debra Saxe, et al.
Blood
|
March 21, 2009
Generation of induced pluripotent stem cells from human blood
Yuin-Han Loh, Suneet Agarwal, In-Hyun Park, et al.
Neuropharmacology
|
January 1, 1997
The pharmacology of the novel and selective sigma ligand, PD 144418
H C Akunne, S Z Whetzel, J N Wiley, et al.
Journal of Studies on Alcohol and Drugs
|
March 21, 2017
Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men
Melodie Isgro, Neal Doran, Jaimee L Heffner, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia
Meir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Journal of Medicinal Chemistry
|
December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents
P C Unangst, T Capiris, D T Connor, et al.
Journal of Medicinal Chemistry
|
January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties
J C Jaen, L D Wise, B W Caprathe, et al.
Brain : a Journal of Neurology
|
October 13, 2006
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome
Mario Masellis, Parastoo Momeni, Wendy Meschino, et al.
Cancer
|
July 1, 2011
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years
Martha Arellano, Elliott Winton, Lin Pan, et al.
Page
of 103